Top

Reactions Weekly

Published in:

01-01-2023 | Bladder Carcinoma | Case report

Antineoplastics/dexamethasone

Autoimmune encephalitis and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Udovica S, et al. Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature. Memo - Magazine of European Medical Oncology 15: 165-168, No. 2, Jun 2022. Available from: URL: https://www.springer.com/journal/12254

Title: Antineoplastics/dexamethasone
Autoimmune encephalitis and lack of efficacy: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Bladder Carcinoma
Sultamicillin
Bladder Carcinoma
Autoimmune Encephalitis
Urothelial Cancer
Urothelial Cancer
Dexamethasone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30326-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics/dexamethasone

Autoimmune encephalitis and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Amenamevir/pranoprofen

Durvalumab

Prednisolone

Antithrombin-iii/heparin/tozinameran

Elasomeran

Marijuana